China Focus @ BWB
Sept 10, 2019
Boston Convention Center
415 Summer St, Boston, MA 02210
PART OF  Biotech Week Boston


China has embraced a vigorously growing healthcare market in the past decade. Ever since joining ICH in 2017, China has seen increased clinical trials and accelerated new drug and device approval. For biotech and medtech companies outside of China, you need to find the right partners and the right resources to bring your products to China, in order to adapt to difference in culture, regulation, reimbursement, etc. In the meantime, Chinese biotechs are actively seeking global market entry opportunities and oversea partners.

China Focus @BWB Boston is designed to provide a meaningful platform to inform, inspire, and foster cross-border partnership in life science and healthcare.

Who should attend
  • Investors (VC, PE, investment bank, etc.)
  • Life science innovators and entrepreneurs
  • Biotech & big pharma
  • Medtech (device and diagnostics) manufacturers and distributors
  • Service providers (law firm, financial advisory, regulatory consulting, CRO, CDMO, etc.)
  • Healthcare providers
Main topics
  • Cross-border investment: money from the East and the West
  • Innovations going to China: regulation, market access, manufacturing and distribution
  • Chinese innovations going west: partnership for capital and market access in the U.S.
What you can get
  • Learn about Chinese life science and healthcare industry
  • Hear about the latest Chinese regulatory reforms and implications
  • Meet with the decision makers in the industry
  • Initiate business conversations that otherwise difficult to start
at Previous China Focus Events



Executive Level Attendees

Chinese Companies and Investors

One-to-one meetings




Qualified investors can request
complimentary registration

Member of the press can request for a complimentary registration

Download Sample Attendee List from past China Focus events

Download Program from past China Focus events

Time Plenary session
8:30 AM – 9:10 AM Opening Remark
Keynote: Rise of the Chinese healthcare market and opportunities for investment and collaboration
9:10 AM – 10:10 AM Panel 1: Cross-border partnership in a new era of globalization and innovation
Moderator: Kim Nearing – Managing Director, Cedrus Group
Lei (Geffrey) Gao – Executive VP/Deputy General Manager, Harbin Pharma
Qingxi (Charles) Wang – Executive Director/ Vice President, CSPC Pharmaceutical Group
10:10 AM – 10:30 AM Break
10:30 AM – 11:00 AM Featured Talk: Regulatory reforms in China and the impact on cross-border partnership in the healthcare industry
Dan Zhang – Executive Chairman, FMD K&L
11:00 AM – 12:00 PM Panel 2: Chinese biopharma’s diverse strategies to meet the domestic and global needs of innovation
Moderator: Danhui Wang – Founding Partner, Remedeca Partners LLC
Xiyong (Sean) Fu – President, Luye Boston R&D LLC
Lijun Wu – Chief Scientific Officer, Fosun Pharma US
12:00 PM – 1:00 PM Lunch break
1:00 PM – 1:20 PM Featured Talk: Cell and gene therapy in and out of China – opportunities for collaboration
Wei (William) Cao – CEO, Gracell Biotechnologies
1:20 PM – 2:10 PM Panel 3: China’s growing role in a global battle against cancer
Moderator: Brad Loncar – CEO, Loncar Investments
Xiangyang (Sean) Zhang – CEO, Hengrui Therapeutics
Wei (William) Cao – CEO, Gracell Biotechnologies
2:10 PM – 3:00 PM Chinese company showcase
3:20 PM – 3:20 PM Break
3:20 PM – 4:10 PM Panel 4: Establish a global strategy of clinical development that fits your goal
Moderator: TBD

4:10 PM – 5:00 PM

Panel 5: Winning recipes in a competitive landscape of licensing – What can we learn from the experiences of recent deal makers?

Moderator: Jie Liu – Managing Director, Torreya Partners
Samuel Murphy – VP and Head of International BD, Salubris Pharmaceuticals


(by surnames in alphabetic order)

Wei (William) Cao

Chairman and CEO

Gracell Biotechnologies

Xi-Yong (Sean) Fu


Luye Boston R&D LLC

Lei (Geffrey) Gao

Executive VP/Deputy General Manager

Harbin Pharma

Jie (Jay) Liu

Managing Director

Torreya Partners

Brad Loncar


Loncar Investments

Samuel Murphy

VP and Head of International BD

Salubris Pharmaceuticals

Kim Nearing

Managing Director

Cedrus Group

Danhui Wang

Founding partner

Remedeca Partners LLC

Lijun Wu


Fosun Pharma US

Dan Zhang

Executive Chairman


Xiangyang (Sean) Zhang


Hengrui Therapeutics


Participating Companies


9 + 12 =

Registration, Sponsorship and Collaboration (China)

Youwen (Allen) Dai

Registration, Sponsorship and Collaboration (U.S. and Europe)

Xinxin Li
Speaker, Group Delegation and Presenting Companies

Han Yan




Boston Convention Center 415 Summer St, Boston, MA 02210

Phone: 617-954-2000
Fax: 617-954-2299